Physician profile
Maximo E Lama
NPI 1326276445
$254,767.23
in general payments reported to CMS, 2019-2025
60 companies · $21K in 2025
The $21K reported for 2025 was more than what 97% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,507 · 2020: $12K · 2021: $42K · 2022: $59K · 2023: $61K · 2024: $56K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $118K · Food and Beverage: $17K · Travel and Lodging: $1,487 · Education: $448.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $118,440.00 |
| Food and Beverage | $17,361.56 |
| Travel and Lodging | $1,486.74 |
| Education | $448.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $205,607.40 | 2019-2025 | Arexvy, Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals Lp | $28,261.52 | 2019-2025 | Breztri, Tezspire, Fasenra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $3,226.17 | 2019-2025 | Ofev, Spiriva Respimat, Jascayd |
| Actelion Pharmaceuticals US, INC. | $2,727.51 | 2019-2025 | Uptravi, Opsumit |
| Grifols USA, LLC | $1,809.50 | 2019-2025 | Prolastin-C Liquid, Xembify, Gamunex-C |
| Regeneron Healthcare Solutions, INC. | $1,089.07 | 2019-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $1,055.68 | 2020-2025 | Glassia, Cuvitru |
| Genzyme Corporation | $973.31 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $958.46 | 2019-2025 | |
| United Therapeutics Corporation | $925.48 | 2019-2025 | Tyvaso |
| Philips North America LLC | $801.86 | 2019-2024 | (Ak6) Vest Therapy |
| Mylan Specialty L.P. | $798.20 | 2019-2024 | Yupelri |
| Insmed, INC. | $641.06 | 2019-2025 | Arikayce, Brinsupri |
| Amgen INC. | $615.06 | 2021-2025 | Tezspire |
| Genentech USA, INC. | $482.94 | 2019-2024 | Xolair |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $420.64 | 2020-2023 | Wakix |
| Bayer Healthcare Pharmaceuticals INC. | $323.54 | 2019-2024 | |
| Paratek Pharmaceuticals, INC. | $316.41 | 2022-2025 | Nuzyra |
| Sunovion Pharmaceuticals INC. | $309.92 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $292.38 | 2019-2025 | |
| Allergan, INC. | $234.56 | 2019 | |
| Axsome Therapeutics, INC. | $230.83 | 2024-2025 | Sunosi |
| Vapotherm INC | $202.52 | 2019-2023 | Vapotherm |
| Merck Sharp & Dohme LLC | $194.74 | 2021-2025 | Winrevair |
| Zoll Respicardia, INC. | $188.05 | 2021 | |
| Pulmonx Corporation | $180.53 | 2024 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Mallinckrodt Hospital Products INC. | $170.74 | 2025 | Terlivaz, Acthar |
| E.R. Squibb & Sons, L.L.C. | $154.93 | 2019-2022 | |
| Verona Pharma, INC. | $148.61 | 2025 | Ohtuvayre |
| Idorsia Pharmaceuticals US INC | $130.36 | 2023 | Quviviq |
| Inspire Medical Systems, INC. | $125.77 | 2025 | Inspire |
| Electromed, INC. | $94.22 | 2021-2023 | Smartvest |
| Vifor Pharma, INC. | $93.58 | 2024-2025 | Zemaira, Veltassa |
| Ani Pharmaceuticals, INC. | $91.91 | 2023-2024 | Purified Cortrophin Gel |
| Teva Pharmaceuticals USA, INC. | $90.59 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $89.00 | 2022 | |
| Portola Pharmaceuticals, LLC | $87.93 | 2019 | |
| Pfizer INC. | $66.07 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $57.22 | 2021-2022 | |
| Tactile Systems Technology INC | $41.09 | 2024 | Entre Plus, Flexitouch Plus |
| Lilly USA, LLC | $37.23 | 2025 | Zepbound |
| Inogen, INC. | $36.51 | 2022 | |
| Ethicon INC. | $32.02 | 2021 | |
| Greer Laboratories, INC. | $29.08 | 2019 | |
| Shire North American Group INC | $27.65 | 2019 | |
| Advanced Respiratory, INC | $26.56 | 2021 | |
| Avadel Cns Pharmaceuticals, LLC | $26.18 | 2025 | Lumryz |
| Alk-Abello, INC | $25.98 | 2019 | |
| Circassia INC. | $24.57 | 2019 | |
| Sandoz INC. | $24.09 | 2019 | |
| Viatris Specialty LLC | $22.78 | 2025 | Yupelri |
| Fisher & Paykel Healthcare INC | $18.96 | 2023 | Fisher & Paykel Healthcare |
| Baxter Healthcare | $18.73 | 2023 | Hillrom - Life 2000 Ventilation System |
| Optinose US, INC. | $18.57 | 2024 | |
| Hikma Pharmaceuticals USA | $17.04 | 2023 | Ryaltris |
| Biogen, INC. | $16.41 | 2021 | |
| Resmed Corp | $16.21 | 2020 | |
| Boston Scientific Corporation | $13.33 | 2022 | |
| Phadia US INC. | $13.04 | 2023 | Immunocap |
| Nabriva Therapeutics, Plc | $12.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maximo Lama listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.